CCR10 antagonist 1

CAS No. 1191031-97-6

CCR10 antagonist 1( —— )

Catalog No. M10657 CAS No. 1191031-97-6

CCR10 antagonist 1 is a potent, selective CCR10 antagonist with IC50 of 690 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CCR10 antagonist 1
  • Note
    Research use only, not for human use.
  • Brief Description
    CCR10 antagonist 1 is a potent, selective CCR10 antagonist with IC50 of 690 nM.
  • Description
    CCR10 antagonist 1 is a potent, selective CCR10 antagonist with IC50 of 690 nM; demonstrates functional CCR1 antagonism by inhibiting the CCL27 dependent chemotaxis of Ba/F3 cells stably transfected with human CCR10 with an IC50 of 53 nM, exhibits no antagonism of murine CCL27 dependent Ca2+ flux in CHO-K cells stably transfected with murine CCR10 at 20 uM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Chemokine Receptor
  • Recptor
    Chemokine Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1191031-97-6
  • Formula Weight
    519.398
  • Molecular Formula
    C19H24Cl2N6O5S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    4-amino-3,5-dichloro-N-(1-(4-methylpiperidin-1-yl)-4-(2-nitro-1H-imidazol-1-yl)-1-oxobutan-2-yl)benzenesulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Abeywardane A, et al. Bioorg Med Chem Lett. 2016 Nov 1;26(21):5277-5283.
molnova catalog
related products
  • CX797

    A potent, specfic CXCR2 antagonist that inhibits IL8 down-regulation of forskolin-induced cAMP with IC50 of 7.79 uM.

  • CCX140

    A potent, selective, orally bioavailable CCR2 antagonist with Kd of 2.3 nM for hCCR2.

  • BI 6901

    BI 6901 is a potent, selective CCR10 antagonist with Aequorin Ca2+ flux pIC50 of 9.0.